7-139872324-G-A

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001061.7(TBXAS1):​c.179G>A​(p.Arg60His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00183 in 1,613,452 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R60C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 5 hom. )

Consequence

TBXAS1
NM_001061.7 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 0.273
Variant links:
Genes affected
TBXAS1 (HGNC:11609): (thromboxane A synthase 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. The enzyme plays a role in several pathophysiological processes including hemostasis, cardiovascular disease, and stroke. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008380592).
BP6
Variant 7-139872324-G-A is Benign according to our data. Variant chr7-139872324-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 547027.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Benign=1}. Variant chr7-139872324-G-A is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TBXAS1NM_001061.7 linkuse as main transcriptc.179G>A p.Arg60His missense_variant 2/13 ENST00000448866.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TBXAS1ENST00000448866.7 linkuse as main transcriptc.179G>A p.Arg60His missense_variant 2/131 NM_001061.7 P1P24557-1

Frequencies

GnomAD3 genomes
AF:
0.00131
AC:
200
AN:
152100
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000314
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00255
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00218
Gnomad OTH
AF:
0.000955
GnomAD3 exomes
AF:
0.00171
AC:
430
AN:
251374
Hom.:
1
AF XY:
0.00173
AC XY:
235
AN XY:
135852
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00118
Gnomad FIN exome
AF:
0.00296
Gnomad NFE exome
AF:
0.00260
Gnomad OTH exome
AF:
0.00179
GnomAD4 exome
AF:
0.00188
AC:
2753
AN:
1461234
Hom.:
5
Cov.:
31
AF XY:
0.00186
AC XY:
1350
AN XY:
726948
show subpopulations
Gnomad4 AFR exome
AF:
0.000329
Gnomad4 AMR exome
AF:
0.000157
Gnomad4 ASJ exome
AF:
0.00157
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.000974
Gnomad4 FIN exome
AF:
0.00309
Gnomad4 NFE exome
AF:
0.00212
Gnomad4 OTH exome
AF:
0.00144
GnomAD4 genome
AF:
0.00131
AC:
200
AN:
152218
Hom.:
0
Cov.:
32
AF XY:
0.00136
AC XY:
101
AN XY:
74416
show subpopulations
Gnomad4 AFR
AF:
0.000313
Gnomad4 AMR
AF:
0.000262
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.00255
Gnomad4 NFE
AF:
0.00218
Gnomad4 OTH
AF:
0.000945
Alfa
AF:
0.00202
Hom.:
0
Bravo
AF:
0.00119
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00233
AC:
20
ExAC
AF:
0.00191
AC:
232
EpiCase
AF:
0.00262
EpiControl
AF:
0.00219

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 15, 2023- -
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenFeb 01, 2018- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpOct 20, 2023Variant summary: TBXAS1 c.179G>A (p.Arg60His) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0017 in 251374 control chromosomes in the gnomAD database, including 1 homozygote. c.179G>A has been reported in the literature in an individual affected with a bleeding disorder without strong evidence of causality (e.g. Leine_2017). This report does not provide unequivocal conclusions about association of the variant with Ghosal Hematodiaphyseal Dysplasia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 28748566). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014, classifying variant as benign (n=1) or uncertain significance (n=1). Based on the evidence outlined above, the variant was classified as uncertain significance. -
TBXAS1-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesDec 08, 2023This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
14
DANN
Benign
0.94
DEOGEN2
Benign
0.058
T;.;.;.;T;T;.
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.69
FATHMM_MKL
Benign
0.35
N
LIST_S2
Benign
0.70
T;.;.;T;T;.;T
M_CAP
Benign
0.013
T
MetaRNN
Benign
0.0084
T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
1.0
D;D;D;D;D;D;D;D;D;D;D
PrimateAI
Benign
0.27
T
PROVEAN
Uncertain
-2.5
D;.;.;.;.;.;.
REVEL
Benign
0.059
Sift
Benign
0.13
T;.;.;.;.;.;.
Sift4G
Benign
0.44
T;.;.;.;.;.;.
Polyphen
0.081, 0.032
.;.;B;B;B;.;.
Vest4
0.14
MVP
0.20
MPC
0.15
ClinPred
0.020
T
GERP RS
1.0
gMVP
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6138; hg19: chr7-139572123; COSMIC: COSV105043873; API